 PHILADELPHIA, Aug. 27, 2021 GLOBE NEWSWIRE -- Passage Bio, Inc. Nasdaq: PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system CNS disorders, today announced it has granted inducement awards to the companys newly appointed Chief Financial Officer, Simona King, and eight other individuals under an inducement plan adopted by its board of directors. 